Cargando…
Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient
We present a case of a 55-year-old man with a heart transplant who acquired Invasive Aspergillosis by Aspergillus fumigatus with the focus in the kidney. During about two years of antifungal treatment, most of the time with voriconazole, it was possible to obtain nine isolates of A. fumigatus, with...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881195/ https://www.ncbi.nlm.nih.gov/pubmed/35242508 http://dx.doi.org/10.1016/j.mmcr.2022.02.002 |
_version_ | 1784659414165225472 |
---|---|
author | Pontes, Laís Gualtieri Beraquet, Caio Augusto Arai, Teppei Watanabe, Akira Moretti, Maria Luiza Schreiber, Angelica Zaninelli |
author_facet | Pontes, Laís Gualtieri Beraquet, Caio Augusto Arai, Teppei Watanabe, Akira Moretti, Maria Luiza Schreiber, Angelica Zaninelli |
author_sort | Pontes, Laís |
collection | PubMed |
description | We present a case of a 55-year-old man with a heart transplant who acquired Invasive Aspergillosis by Aspergillus fumigatus with the focus in the kidney. During about two years of antifungal treatment, most of the time with voriconazole, it was possible to obtain nine isolates of A. fumigatus, with the same genotypic characteristics, but with an increase in MIC for several azoles. The two last isolates presented high MICs for Voriconazole (>8 μg/mL>). Sequencing of the CYP51A gene showed G448S amino acid substitution in the same two isolates. In long-term treatments with antifungals, it would be important to regularly evaluate the susceptibility of isolated strains, as resistance to azoles has been increasingly described around the world. |
format | Online Article Text |
id | pubmed-8881195 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-88811952022-03-02 Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient Pontes, Laís Gualtieri Beraquet, Caio Augusto Arai, Teppei Watanabe, Akira Moretti, Maria Luiza Schreiber, Angelica Zaninelli Med Mycol Case Rep Case Report We present a case of a 55-year-old man with a heart transplant who acquired Invasive Aspergillosis by Aspergillus fumigatus with the focus in the kidney. During about two years of antifungal treatment, most of the time with voriconazole, it was possible to obtain nine isolates of A. fumigatus, with the same genotypic characteristics, but with an increase in MIC for several azoles. The two last isolates presented high MICs for Voriconazole (>8 μg/mL>). Sequencing of the CYP51A gene showed G448S amino acid substitution in the same two isolates. In long-term treatments with antifungals, it would be important to regularly evaluate the susceptibility of isolated strains, as resistance to azoles has been increasingly described around the world. Elsevier 2022-02-18 /pmc/articles/PMC8881195/ /pubmed/35242508 http://dx.doi.org/10.1016/j.mmcr.2022.02.002 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Case Report Pontes, Laís Gualtieri Beraquet, Caio Augusto Arai, Teppei Watanabe, Akira Moretti, Maria Luiza Schreiber, Angelica Zaninelli Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient |
title | Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient |
title_full | Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient |
title_fullStr | Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient |
title_full_unstemmed | Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient |
title_short | Selection of Aspergillus fumigatus isolates carrying the G448S substitution in CYP51A gene after long-term treatment with voriconazole in an immunocompromised patient |
title_sort | selection of aspergillus fumigatus isolates carrying the g448s substitution in cyp51a gene after long-term treatment with voriconazole in an immunocompromised patient |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8881195/ https://www.ncbi.nlm.nih.gov/pubmed/35242508 http://dx.doi.org/10.1016/j.mmcr.2022.02.002 |
work_keys_str_mv | AT ponteslais selectionofaspergillusfumigatusisolatescarryingtheg448ssubstitutionincyp51ageneafterlongtermtreatmentwithvoriconazoleinanimmunocompromisedpatient AT gualtieriberaquetcaioaugusto selectionofaspergillusfumigatusisolatescarryingtheg448ssubstitutionincyp51ageneafterlongtermtreatmentwithvoriconazoleinanimmunocompromisedpatient AT araiteppei selectionofaspergillusfumigatusisolatescarryingtheg448ssubstitutionincyp51ageneafterlongtermtreatmentwithvoriconazoleinanimmunocompromisedpatient AT watanabeakira selectionofaspergillusfumigatusisolatescarryingtheg448ssubstitutionincyp51ageneafterlongtermtreatmentwithvoriconazoleinanimmunocompromisedpatient AT morettimarialuiza selectionofaspergillusfumigatusisolatescarryingtheg448ssubstitutionincyp51ageneafterlongtermtreatmentwithvoriconazoleinanimmunocompromisedpatient AT schreiberangelicazaninelli selectionofaspergillusfumigatusisolatescarryingtheg448ssubstitutionincyp51ageneafterlongtermtreatmentwithvoriconazoleinanimmunocompromisedpatient |